Weight-loss drugs like Ozempic and Wegovy have gained popularity, with an estimated 15.5 million U.S. adults using injectable diabetes medicines for weight loss. Common myths surrounding these drugs include the belief that they can work miracles without changes to diet or exercise habits. GLP-1 agonists, a class of medications that include Ozempic and Wegovy, were named Breakthrough of the Year in 2023 for their potential in combating 'diabesity.' Physicians have noted that despite the drugs' popularity, most have not been trained to use them effectively.
1/ Weight loss drugs like Ozempic & Wegovy are more popular, but most physicians haven't been trained to use them https://t.co/3DQfTfmDso with @CBSNews' @AMGreenCBS https://t.co/iJqAx0u2lt
Heard of Ozempic/Wegovy? These drugs are part of a class of medications called GLP-1 agonists. In 2023, Science named GLP-1 agonists Breakthrough of the Year for their potential to combat "diabesity", 1 year after JWST won the same award. Let's ask why. 🧵OPEN THE THREAD🧵 https://t.co/dn38TZJvB6
An estimated 15.5 million American adults have used injectable diabetes medicines like Ozempic to lose weight, according to a new Gallup poll. https://t.co/xzBEIXgG6j https://t.co/79PYzGJXy5
An estimated 15.5 million U.S. adults have used injectable diabetes medicines like Ozempic and Wegovy to lose weight, according to a Gallup poll released Tuesday. https://t.co/lrwWyF0y5n
An estimated 15.5 million U.S. adults have used injectable diabetes medicines like Ozempic and Wegovy to lose weight, according to a Gallup poll released Tuesday https://t.co/x4h9iGrzDA
Here are the most common myths about weight-loss drugs. https://t.co/yng98BuTm7
Perhaps the biggest myth of all surrounding the weight-loss drugs is that they can work miracles for weight loss, without changes to diet or exercise habits. https://t.co/FkUOLtyCpF
Dr. Sterling Elliott tackles some of the most common myths about weight-loss drugs. Here is what he had to say: https://t.co/TTWBP7RK4C
Learn some of the common myths about weight-loss drugs. https://t.co/WlArHLh8Tt
The most common myths about weight-loss drugs https://t.co/sgpkC0wRuA
These are the most common myths about weight-loss drugs: https://t.co/ncoBPXZiU4
GLP-1 drug prescriptions have rapidly increased since 2020. https://t.co/GuPWnXYbJa
The number of young people in the U.S. who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and diabetes soared 600% in just three years. https://t.co/jbvGrJhBAK
Young people’s use of diabetes and weight loss drugs like Ozempic and Wegovy is surging, especially among females ages 18 to 25. https://t.co/GuPWnXYbJa